
|Articles|May 21, 2007
Latebreakers: Transdermal option given OK for Parkinson's disease
A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Can Play Central Role in Patients’ Infusion Services | ASHP Midyear 2025
2
Women Seek Holistic Interventions for Improving Health Outcomes
3
What TrumpRx Means for Independent Pharmacies and Their Patients
4
Social and Economic Factors Significantly Influence Supply of OTC Antibiotics
5




























































































































